Three-Day Icatibant on Top of Standard Care in Patients With Coronavirus Disease 2019 Pneumonia: A Randomized, Open-Label, Phase 2, Proof-of-Concept Trial
Malchair et al., Clinical Infectious Diseases, doi:10.1093/cid/ciac984
https://c19early.org/malchair.html